300 related articles for article (PubMed ID: 15629532)
1. Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock.
Giacometti A; Cirioni O; Ghiselli R; Orlando F; Kamysz W; Rocchi M; D'Amato G; Mocchegiani F; Silvestri C; Łukasiak J; Saba V; Scalise G
Peptides; 2005 Feb; 26(2):207-16. PubMed ID: 15629532
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models.
Giacometti A; Ghiselli R; Cirioni O; Mocchegiani F; D'Amato G; Orlando F; Sisti V; Kamysz W; Silvestri C; Naldoski P; Lukasiak J; Saba V; Scalise G
J Antimicrob Chemother; 2004 Sep; 54(3):654-60. PubMed ID: 15294887
[TBL] [Abstract][Full Text] [Related]
3. Cecropin B enhances betalactams activities in experimental rat models of gram-negative septic shock.
Ghiselli R; Giacometti A; Cirioni O; Mocchegiani F; Orlando F; D'Amato G; Sisti V; Scalise G; Saba V
Ann Surg; 2004 Feb; 239(2):251-6. PubMed ID: 14745334
[TBL] [Abstract][Full Text] [Related]
4. LL-37 protects rats against lethal sepsis caused by gram-negative bacteria.
Cirioni O; Giacometti A; Ghiselli R; Bergnach C; Orlando F; Silvestri C; Mocchegiani F; Licci A; Skerlavaj B; Rocchi M; Saba V; Zanetti M; Scalise G
Antimicrob Agents Chemother; 2006 May; 50(5):1672-9. PubMed ID: 16641434
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of the bovine antimicrobial peptide indolicidin combined with piperacillin/tazobactam in experimental rat models of polymicrobial peritonitis.
Ghiselli R; Giacometti A; Cirioni O; Mocchegiani F; Orlando F; Silvestri C; Di Matteo F; Abbruzzetti A; Scalise G; Saba V
Crit Care Med; 2008 Jan; 36(1):240-5. PubMed ID: 18090372
[TBL] [Abstract][Full Text] [Related]
6. Potential therapeutic role of histatin derivative P-113d in experimental rat models of Pseudomonas aeruginosa sepsis.
Cirioni O; Giacometti A; Ghiselli R; Orlando F; Kamysz W; D'Amato G; Mocchegiani F; Lukasiak J; Silvestri C; Saba V; Scalise G
J Infect Dis; 2004 Jul; 190(2):356-64. PubMed ID: 15216473
[TBL] [Abstract][Full Text] [Related]
7. Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock.
Giacometti A; Cirioni O; Ghiselli R; Mocchegiani F; D'Amato G; Circo R; Orlando F; Skerlavaj B; Silvestri C; Saba V; Zanetti M; Scalise G
Am J Respir Crit Care Med; 2004 Jan; 169(2):187-94. PubMed ID: 14563656
[TBL] [Abstract][Full Text] [Related]
8. Neutralization of endotoxin in vitro and in vivo by Bac7(1-35), a proline-rich antibacterial peptide.
Ghiselli R; Giacometti A; Cirioni O; Circo R; Mocchegiani F; Skerlavaj B; D'Amato G; Scalise G; Zanetti M; Saba V
Shock; 2003 Jun; 19(6):577-81. PubMed ID: 12785015
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic efficacy of the polymyxin-like peptide ranalexin in an experimental model of endotoxemia.
Ghiselli R; Giacometti A; Cirioni O; Orlando F; Mocchegiani F; Pacci AM; Scalise G; Saba V
J Surg Res; 2001 Oct; 100(2):183-8. PubMed ID: 11592790
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of citropin 1.1 and tazobactam-piperacillin against oxidative damage and lethality in mice models of gram-negative sepsis.
Ghiselli R; Silvestri C; Cirioni O; Kamysz W; Orlando F; Calcinari A; Kamysz E; Casteletti S; Rimini M; Tocchini M; Giacometti A; Guerrieri M
J Surg Res; 2011 Dec; 171(2):726-33. PubMed ID: 20605608
[TBL] [Abstract][Full Text] [Related]
11. Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria.
Giacometti A; Cirioni O; Ghiselli R; Mocchegiani F; Orlando F; Silvestri C; Bozzi A; Di Giulio A; Luzi C; Mangoni ML; Barra D; Saba V; Scalise G; Rinaldi AC
Antimicrob Agents Chemother; 2006 Jul; 50(7):2478-86. PubMed ID: 16801429
[TBL] [Abstract][Full Text] [Related]
12. Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock.
Giacometti A; Cirioni O; Ghiselli R; Mocchegiani F; Viticchi C; Orlando F; D'Amato G; Del Prete MS; Kamysz W; łLukasiak J; Saba V; Scalise G
Peptides; 2003 Nov; 24(11):1747-52. PubMed ID: 15019206
[TBL] [Abstract][Full Text] [Related]
13. Lipopolysaccharide-binding and neutralizing activities of surfactin C in experimental models of septic shock.
Hwang YH; Park BK; Lim JH; Kim MS; Park SC; Hwang MH; Yun HI
Eur J Pharmacol; 2007 Feb; 556(1-3):166-71. PubMed ID: 17126323
[TBL] [Abstract][Full Text] [Related]
14. Tachyplesin III and granulocyte-colony stimulating factor enhance the efficacy of tazobactam/piperacillin in a neutropenic mouse model of polymicrobial peritonitis.
Cirioni O; Ghiselli R; Kamysz W; Orlando F; Silvestri C; Mocchegiani F; Di Matteo F; Kamysz E; Riva A; Rocchi M; Saba V; Scalise G; Giacometti A
Peptides; 2008 Jan; 29(1):31-8. PubMed ID: 18068869
[TBL] [Abstract][Full Text] [Related]
15. Interaction of antimicrobial peptide s-thanatin with lipopolysaccharide in vitro and in an experimental mouse model of septic shock caused by a multidrug-resistant clinical isolate of Escherichia coli.
Wu G; Fan X; Li L; Wang H; Ding J; Hongbin W; Zhao R; Gou L; Shen Z; Xi T
Int J Antimicrob Agents; 2010 Mar; 35(3):250-4. PubMed ID: 20045294
[TBL] [Abstract][Full Text] [Related]
16. Antiendotoxin activity of antimicrobial peptides and glycopeptides.
Giacometti A; Cirioni O; Ghiselli R; Orlando F; Mocchegiani F; D'Amato G; Silvestri C; Riva A; Del Prete MS; Saba V; Scalise G
J Chemother; 2003 Apr; 15(2):129-33. PubMed ID: 12797388
[TBL] [Abstract][Full Text] [Related]
17. The cathelicidin-derived tritrpticin enhances the efficacy of ertapenem in experimental rat models of septic shock.
Ghiselli R; Cirioni O; Giacometti A; Mocchegiani F; Orlando F; Silvestri C; Licci A; Della Vittoria A; Scalise G; Saba V
Shock; 2006 Aug; 26(2):195-200. PubMed ID: 16878029
[TBL] [Abstract][Full Text] [Related]
18. Potential therapeutic role of cationic peptides in three experimental models of septic shock.
Giacometti A; Cirioni O; Ghiselli R; Mocchegiani F; Del Prete MS; Viticchi C; Kamysz W; ŁEmpicka E; Saba V; Scalise G
Antimicrob Agents Chemother; 2002 Jul; 46(7):2132-6. PubMed ID: 12069965
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of colistin/rifampin combination in experimental rat models of sepsis due to a multiresistant Pseudomonas aeruginosa strain.
Cirioni O; Ghiselli R; Orlando F; Silvestri C; Mocchegiani F; Rocchi M; Chiodi L; Abbruzzetti A; Saba V; Scalise G; Giacometti A
Crit Care Med; 2007 Jul; 35(7):1717-23. PubMed ID: 17452938
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of the combination of alpha-helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection.
Cirioni O; Silvestri C; Ghiselli R; Orlando F; Riva A; Mocchegiani F; Chiodi L; Castelletti S; Gabrielli E; Saba V; Scalise G; Giacometti A
J Antimicrob Chemother; 2008 Dec; 62(6):1332-8. PubMed ID: 18799470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
